{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:57:29Z","timestamp":1792461449145,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,6,18]],"date-time":"2009-06-18T00:00:00Z","timestamp":1245283200000},"content-version":"vor","delay-in-days":109,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1590\/s1807-59322009000300016","type":"journal-article","created":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T15:20:32Z","timestamp":1237994432000},"page":"245-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Selective Cyclooxygenase-2 Inhibition Protects Against Myocardial Damage in Experimental Acute Ischemia"],"prefix":"10.1016","volume":"64","author":[{"suffix":"Jr.","given":"Alberto","family":"Carnieto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Magno Martins","family":"Dourado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prot\u00e1sio Lemos","family":"da Luz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Carlos Palandri","family":"Chagas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1590\/S1807-59322009000300016_bib1","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1172\/JCI112160","article-title":"Myocardial reperfusion: a double-edged sword?","volume":"76","author":"Braunwald","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1590\/S1807-59322009000300016_bib2","first-page":"303","article-title":"Myocardial Reperfusion Injury: Insights Gained from Gene-Targeted Mice","volume":"15","author":"Jones","year":"2000","journal-title":"News Physiol Sci"},{"issue":"2","key":"10.1590\/S1807-59322009000300016_bib3","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0022-3565(25)21794-3","article-title":"Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs","volume":"228","author":"Mullane","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"10.1590\/S1807-59322009000300016_bib4","first-page":"405","article-title":"Methylprednisolone interventions in myocardial infarction: a controversial subject","volume":"6","author":"LeGal","year":"1990","journal-title":"Can J Cardiol"},{"issue":"3 Suppl","key":"10.1590\/S1807-59322009000300016_bib5","first-page":"I204","article-title":"Deleterious effects of methylprednisolone in patients with myocardial infarction","volume":"53","author":"Roberts","year":"1976","journal-title":"Circulation"},{"issue":"24","key":"10.1590\/S1807-59322009000300016_bib6","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1053\/euhj.2000.2475","article-title":"A randomized placebo-controlled trial to assess the efficacy of antiinflammatory therapy with methylprednisolone in unstable angina (MUNA trial)","volume":"21","author":"Azar","year":"2000","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1590\/S1807-59322009000300016_bib7","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0002-9149(99)00068-5","article-title":"Nonsteroidal anti-inflammatory drugs after acute myocardial infarction. DAVIT Study Group. Danish Verapamil Infarction Trial","volume":"15;83","author":"Sajadieh","year":"1999","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1590\/S1807-59322009000300016_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/01.CIR.0000021599.56755.A1","article-title":"Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation: the Nonsteroidal Anti-Inflammatory Drugs in Unstable Angina Treatment-2 (NUT-2) pilot study","volume":"9;106","author":"Altman","year":"2002","journal-title":"Circulation"},{"issue":"7311","key":"10.1590\/S1807-59322009000300016_bib9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/bmj.323.7311.471a","article-title":"COX 2 inhibitors may increase risk of heart attack","volume":"1;323","author":"Gottlieb","year":"2001","journal-title":"BMJ"},{"issue":"2","key":"10.1590\/S1807-59322009000300016_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/01.CIR.0000025261.58465.62","article-title":"Cyclooxygenase-2 inhibition and cardiovascular events","volume":"9;106","author":"Pitt","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1590\/S1807-59322009000300016_bib11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/1074248408323136","article-title":"The Risk of Acute Myocardial Infarction With Etodolac is Not Increased Compared to Naproxen: A Historical Cohort Analysis of a Generic COX-2 Selective Inhibitor","volume":"13","author":"Warner","year":"2008","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"6","key":"10.1590\/S1807-59322009000300016_bib12","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/pds.1590","article-title":"Risk of ischaemic cardiovascular events from selective cyclooxygenase-2 inhibitors in osteoarthritis","volume":"17","author":"Cunnington","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1590\/S1807-59322009000300016_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.JCN.0000305054.50506.59","article-title":"Use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs in high doses increases mortality and risk of reinfarction in patients with prior myocardial infarction","volume":"23","author":"Sorensen","year":"2008","journal-title":"J Cardiovasc Nurs"},{"key":"10.1590\/S1807-59322009000300016_bib14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1749-6632.2000.tb06318.x","article-title":"Endothelial dysfunction, hemodynamic forces, and atherogenesis","volume":"902","author":"Gimbrone","year":"2000","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1590\/S1807-59322009000300016_bib15","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0002-9440(10)64092-8","article-title":"Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice","volume":"158","author":"Keerthisingam","year":"2001","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1590\/S1807-59322009000300016_bib16","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/9550","article-title":"Inducible cyclooxygenase may have anti-inflammatory properties","volume":"5","author":"Gilroy","year":"1999","journal-title":"Nat Med"},{"issue":"2","key":"10.1590\/S1807-59322009000300016_bib17","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1006\/bbrc.2000.3010","article-title":"Inhibition of cyclooxygenase-2 improves cardiac function in myocardial infarction","volume":"5;273","author":"Saito","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1590\/S1807-59322009000300016_bib18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1139\/y03-023","article-title":"Cyclooxygenase-2 (COX-2) in acute myocardial infarction: cellular expression and use of selective COX-2 inhibitor","volume":"81","author":"Saito","year":"2003","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1590\/S1807-59322009000300016_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.yjmcc.2004.04.002","article-title":"Inhibition of COX pathway in experimental myocardial infarction","volume":"37","author":"Saito","year":"2004","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"10.1590\/S1807-59322009000300016_bib20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/FJC.0b013e31814b91cb","article-title":"Protective effects of parecoxib, a cyclo-oxygenase-2 inhibitor, in postinfarction remodeling in the rat","volume":"50","author":"Straino","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"10.1590\/S1807-59322009000300016_bib21","doi-asserted-by":"crossref","first-page":"H1416","DOI":"10.1152\/ajpheart.00136.2003","article-title":"Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse","volume":"286","author":"LaPointe","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"10.1590\/S1807-59322009000300016_bib22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/CIRCULATIONAHA.106.647230","article-title":"Cyclooxygenase-2 inhibition increases mortality, enhances left ventricular remodeling, and impairs systolic function after myocardial infarction in the pig","volume":"23;115","author":"Timmers","year":"2007","journal-title":"Circulation"},{"issue":"18","key":"10.1590\/S1807-59322009000300016_bib23","doi-asserted-by":"crossref","first-page":"10197","DOI":"10.1073\/pnas.97.18.10197","article-title":"Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits","volume":"29;97","author":"Shinmura","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1590\/S1807-59322009000300016_bib24","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/sj.bjp.0704585","article-title":"Inhibition of cyclo-oxygenase-2 exacerbates ischaemia-induced acute myocardial dysfunction in the rabbit","volume":"135","author":"Rossoni","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1590\/S1807-59322009000300016_bib25","series-title":"Fundamentals of Biostatistics","author":"Rosner","year":"1986"},{"key":"10.1590\/S1807-59322009000300016_bib26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.HYP.34.3.503","article-title":"Inhibition of the rennin-angiotensin system upregulates cyclooxygenase-2 expression in the macula dense","volume":"34","author":"Wolf","year":"1999","journal-title":"Hypertension"},{"issue":"part 2","key":"10.1590\/S1807-59322009000300016_bib27","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/01.HYP.34.4.843","article-title":"Cyclooxygenase-2 modulates afferent arteriolar responses to increases in pressure","volume":"34","author":"Ichihara","year":"1999","journal-title":"Hypertension"},{"issue":"2 Part 2","key":"10.1590\/S1807-59322009000300016_bib28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/01.HYP.37.2.733","article-title":"Long-term glucose infusion increases arterial pressure in dogs with cyclooxygenase-2 inhibition","volume":"37","author":"Brands","year":"2001","journal-title":"Hypertension"},{"key":"10.1590\/S1807-59322009000300016_bib29","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/01.HYP.0000041221.13644.B9","article-title":"Cyclooxygenase-2 inhibition attenuates lip polysaccharide-induced cardiovascular failure","volume":"40","author":"H\u00f6cherl","year":"2002","journal-title":"Hypertension"},{"key":"10.1590\/S1807-59322009000300016_bib30","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1161\/hc4901.101350","article-title":"Cyclooxygenase-2 blockade does not impair endothelial vasodilator function in healthy volunteers","volume":"104","author":"Verma","year":"2001","journal-title":"Circulation"},{"key":"10.1590\/S1807-59322009000300016_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0009-8981(00)00409-5","article-title":"Cardiac troponins and creatine kinase content of striated muscle in common laboratory animals","volume":"304","author":"Fredericks","year":"2001","journal-title":"Clinica Chimica Acta"},{"key":"10.1590\/S1807-59322009000300016_bib32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0165-2427(01)00319-1","article-title":"Localization of cyclooxygenase isozymes in cardiovascular tissue of dogs treated with naproxen","volume":"80","author":"Stanfield","year":"2001","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1590\/S1807-59322009000300016_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.CIR.93.1.10","article-title":"Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene","volume":"93","author":"Zoldhelyi","year":"1996","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1590\/S1807-59322009000300016_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1007771311374","article-title":"Detection of myocardial damage by serial measurements of cardiac troponin T, CK MBmass, and TROPT rapid test","volume":"11","author":"Gerhardt","year":"1997","journal-title":"Cardiovascular Drugs Therapy"},{"key":"10.1590\/S1807-59322009000300016_bib35","doi-asserted-by":"crossref","first-page":"II328","DOI":"10.1161\/circ.100.suppl_2.Ii-328","article-title":"Serotonin-induced coronary contraction increases after blood cardioplegia-reperfusion. Role of COX-2 expression","volume":"100","author":"M\u00e9tais","year":"1999","journal-title":"Circulation"},{"key":"10.1590\/S1807-59322009000300016_bib36","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0002-9149(99)00068-5","article-title":"Nonsteroidal anti-inflammatory drugs after acute myocardial infarction","volume":"83","author":"Sajadieh","year":"1999","journal-title":"The American Journal of Cardiology"},{"key":"10.1590\/S1807-59322009000300016_bib37","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1053\/euhj.2000.2475","article-title":"A randomized placebo-controlled trial to assess the efficacy of anti-inflammatory therapy with methylpredinisolone in unstable angina (MUNA Trial)","volume":"21","author":"Azar","year":"2000","journal-title":"European Heart Journal"},{"issue":"part 2","key":"10.1590\/S1807-59322009000300016_bib38","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1161\/hy02t2.102808","article-title":"Trophic effects of the cyclooxygenase-2 product prostaglandin E2 in cardiac myocytes","volume":"39","author":"Mendez","year":"2002","journal-title":"Hypertension"},{"key":"10.1590\/S1807-59322009000300016_bib39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.CIR.98.2.100","article-title":"Induction of Cyclooxygenase-2 and Activation of Nuclear Factor-kB in Myocardium of Patients with Congestive Heart Failure","volume":"98","author":"Wong","year":"1998","journal-title":"Circulation"},{"key":"10.1590\/S1807-59322009000300016_bib40","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S1010-7940(01)00846-6","article-title":"IL-8 concentration in coronary sinus blood during early coronary reperfusion after ischemic arrest","volume":"20","author":"Lango","year":"2001","journal-title":"European Journal of Cardio-thoracic Surgery"},{"key":"10.1590\/S1807-59322009000300016_bib41","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.CIR.98.7.699","article-title":"Resident cardiac mast cells degranulate and release preformed canine myocardial ischemic\/reperfusion","volume":"98","author":"Frangogiannis","year":"1998","journal-title":"Circulation"},{"key":"10.1590\/S1807-59322009000300016_bib42","series-title":"Multivariate Analysis with Applications in Educations and Psychology","author":"Timm","year":"1975"},{"key":"10.1590\/S1807-59322009000300016_bib43","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0140-6736(04)17514-4","article-title":"Risk of cardiovascular events and rofecoxib: cumulative meta-analysis","volume":"364","author":"J\u00fcni","year":"2004","journal-title":"Lancet"},{"key":"10.1590\/S1807-59322009000300016_bib44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1510\/icvts.2005.118455","article-title":"A randomized, double-blind, placebo-controlled trial of a COX-2 inhibitor (Rofecoxib) in patients undergoing coronary artery bypass surgery","volume":"5","author":"Wong","year":"2006","journal-title":"Interactive CardioVascular and Thoracic Surgery"},{"key":"10.1590\/S1807-59322009000300016_bib45","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/CIRCULATIONAHA.104.524231","article-title":"Selective cyclooxygenase-2 inhibitors development in cardiovascular medicine","volume":"112","author":"Pratic\u00f2","year":"2005","journal-title":"Circulation"},{"key":"10.1590\/S1807-59322009000300016_bib46","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1161\/CIRCULATIONAHA.105.602425","article-title":"Use of first and second generation cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and risk of acute myocardial infarction","volume":"113","author":"Andersohn","year":"2006","journal-title":"Circulation"},{"key":"10.1590\/S1807-59322009000300016_bib47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/01.CIR.0000151611.89232.3B","article-title":"Endothelial cell activation in patients with decompensated heart failure","volume":"111","author":"Colombo","year":"2005","journal-title":"Circulation"},{"key":"10.1590\/S1807-59322009000300016_bib48","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/pgmj.2005.042234","article-title":"COX-2 inhibitors and the heart: are all coxibs the same?","volume":"82","author":"Sooriakumaran","year":"2006","journal-title":"Postgraduated Medicine Journal"},{"key":"10.1590\/S1807-59322009000300016_bib49","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1161\/01.CIR.0000121354.34067.48","article-title":"Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failure","volume":"109","author":"Delgado","year":"2004","journal-title":"Circulation"},{"key":"10.1590\/S1807-59322009000300016_bib50","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1538\/expanim.56.309","article-title":"Increased level of Serum Vascular Endothelial Growth Factor by long-term exposure to hipergravity","volume":"56","author":"Oshima","year":"2007","journal-title":"Exp Anim"},{"key":"10.1590\/S1807-59322009000300016_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-2094-2-3","article-title":"Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the rat","volume":"2","author":"Candelario-Jalil","year":"2005","journal-title":"Journal of Neuroinflammation"},{"key":"10.1590\/S1807-59322009000300016_bib52","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/FJC.0b013e31804a5e50","article-title":"Improvement of Cardiac Function With Parecoxib, A Cyclo-oxygenase-2 Inhibitor, in a Rat Model of Ischemic Heart Failure","volume":"49","author":"Abbate","year":"2007","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1590\/S1807-59322009000300016_bib53","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/01.CIR.88.2.750","article-title":"Biochemical markers of myocardial injury: Is MB Creatine kinase the choice for the 1990?","volume":"88","author":"Adams","year":"1993","journal-title":"Circulation"},{"key":"10.1590\/S1807-59322009000300016_bib54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.med.45.1.31","article-title":"The earliest diagnosis of acute myocardial infarction","volume":"45","author":"Rozenman","year":"1994","journal-title":"Annu Rev Med"},{"key":"10.1590\/S1807-59322009000300016_bib55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/01.CIR.88.1.101","article-title":"Cardiac Troponin I: a marker with high specificity for cardiac injury","volume":"88","author":"Adams","year":"1993","journal-title":"Circulation"},{"key":"10.1590\/S1807-59322009000300016_bib56","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/clinchem\/40.7.1291","article-title":"Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I","volume":"40","author":"Adams","year":"1994","journal-title":"Clinical Chemistry"},{"key":"10.1590\/S1807-59322009000300016_bib57","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/01.RES.54.3.277","article-title":"Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalyses","volume":"54","author":"Jolly","year":"1984","journal-title":"Circulation Research"},{"key":"10.1590\/S1807-59322009000300016_bib58","series-title":"Faculdade de Medicina da USP","article-title":"\u00d3xido n\u00edtrico na isquemia mioc\u00e1rdica aguda: estudo experimental sobre a prote\u00e7\u00e3o mioc\u00e1rdica no modelo de oclus\u00e3o\/reperfus\u00e3o. Livre-Doc\u00eancia Tese","author":"Chagas","year":"1996"},{"key":"10.1590\/S1807-59322009000300016_bib59","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1172\/JCI107898","article-title":"The \u201cno reflow\u201d phenomenon after temporary coronary occlusion in the dog","volume":"54","author":"Kloner","year":"1974","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1590\/S1807-59322009000300016_bib60","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0002-8703(81)90226-X","article-title":"Early phase myocardial infarct size quantification: Validation of Triphenil Tetrazolium Chloride tissue enzyme staining technique","volume":"101","author":"Fishbein","year":"1981","journal-title":"American Heart Journal"},{"issue":"7","key":"10.1590\/S1807-59322009000300016_bib61","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0149-2918(00)80018-1","article-title":"Selective cyclooxygenase-2 inhibitors for the Ttreatment of arthritis","volume":"21","author":"Fung","year":"1999","journal-title":"Clin Ther"},{"issue":"3","key":"10.1590\/S1807-59322009000300016_bib62","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2165\/00003495-199958030-00016","volume":"58","author":"Scott","year":"1999","journal-title":"Rofecoxib Drugs"},{"key":"10.1590\/S1807-59322009000300016_bib63","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0026-895X(24)12057-3","article-title":"The absortption, distribution, metabolism, and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs","volume":"28","author":"Halpin","year":"2000","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1590\/S1807-59322009000300016_bib64","series-title":"Guide for the Care and Use of Laboratory Animals Institute of Laboratory Animal Resources Commission on Life Sciences","year":"1996"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222026771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222026771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.scielo.br\/pdf\/clin\/v64n3\/v64n3a16.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:15:20Z","timestamp":1761722120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222026771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1807593222026771"],"URL":"https:\/\/doi.org\/10.1590\/s1807-59322009000300016","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective Cyclooxygenase-2 Inhibition Protects Against Myocardial Damage in Experimental Acute Ischemia","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1590\/S1807-59322009000300016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}